Which companies overlap with Louisville Metabolic and Atherosclerosis Research Center's portfolio?

Top competitors by shared drug class: Al-Azhar University, AstraZeneca, Bial - Portela C S.A., CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Cinnagen.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/louisville-metabolic-and-atherosclerosis-research-center.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Louisville Metabolic and Atherosclerosis Research Center — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Louisville Metabolic and Atherosclerosis Research Center pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Tang	Tang	marketed	DPP-4 inhibitor	DPP-4	Diabetes

Therapeutic area mix

Diabetes · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Al-Azhar University · 1 shared drug class
AstraZeneca · 1 shared drug class
Bial - Portela C S.A. · 1 shared drug class
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · 1 shared drug class
Cinnagen · 1 shared drug class
Daewoong Pharmaceutical Co. LTD. · 1 shared drug class
Dong-A ST Co., Ltd. · 1 shared drug class
Ain Shams University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Louisville Metabolic and Atherosclerosis Research Center:

Cite this brief

Drug Landscape (2026). Louisville Metabolic and Atherosclerosis Research Center — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/louisville-metabolic-and-atherosclerosis-research-center. Accessed 2026-05-17.